219 related articles for article (PubMed ID: 27536774)
21. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
23. Role of metastasis-associated protein 1 in prognosis of patients with digestive tract cancers: A meta-analysis.
Cao GD; Chen B; Xiong MM
PLoS One; 2017; 12(6):e0176431. PubMed ID: 28570554
[TBL] [Abstract][Full Text] [Related]
24. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
25. The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients.
Memon AA; Sorensen BS; Meldgaard P; Fokdal L; Thykjaer T; Nexo E
Br J Cancer; 2006 Jun; 94(11):1703-9. PubMed ID: 16685269
[TBL] [Abstract][Full Text] [Related]
26. Roles of human epidermal growth factor receptor family in pulmonary lymphangioleiomyomatosis.
Kobayashi K; Miki Y; Saito R; Adachi K; Seyama K; Okada Y; Sasano H
Hum Pathol; 2018 Nov; 81():121-130. PubMed ID: 30030119
[TBL] [Abstract][Full Text] [Related]
27. Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients.
Memon AA; Sorensen BS; Melgard P; Fokdal L; Thykjaer T; Nexo E
Br J Cancer; 2004 Dec; 91(12):2034-41. PubMed ID: 15583696
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
29. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
30. Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway.
Wu X; Chen Y; Li G; Xia L; Gu R; Wen X; Ming X; Chen H
Med Oncol; 2014 Apr; 31(4):903. PubMed ID: 24623015
[TBL] [Abstract][Full Text] [Related]
31. The role of HER3 in gastric cancer.
Wang L; Yuan H; Li Y; Han Y
Biomed Pharmacother; 2014 Jul; 68(6):809-12. PubMed ID: 25194439
[TBL] [Abstract][Full Text] [Related]
32. Mig6 not only inhibits EGFR and HER2 but also targets HER3 and HER4 in a differential specificity: Implications for targeted esophageal cancer therapy.
Zhong H; He J; Yu J; Li X; Mei Y; Hao L; Wu X
Biochimie; 2021 Nov; 190():132-142. PubMed ID: 34293452
[TBL] [Abstract][Full Text] [Related]
33. HER3 protein expression in relation to HER2 positivity in patients with primary colorectal cancer: clinical relevance and prognostic value.
Seo AN; Kwak Y; Kim WH; Kim DW; Kang SB; Choe G; Lee HS
Virchows Arch; 2015 Jun; 466(6):645-54. PubMed ID: 25739551
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and prognostic significance of LKB1 expression in gastric cancer: a systematic review and meta-analysis.
Tan G; Liu B
Sci Rep; 2023 Jun; 13(1):8937. PubMed ID: 37264076
[TBL] [Abstract][Full Text] [Related]
35. HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
Makatsoris T; Tsamandas AC; Strimpakos A; Alexopoulou Z; Dionysopoulos D; Pervana S; Konstantara A; Papakostas P; Samantas E; Rallis G; Dimou A; Pentheroudakis G; Papaparaskeva K; Psyrri A; Kalogeras KT; Syrigos K; Scopa CD; Fountzilas G
Anticancer Res; 2016 Apr; 36(4):1581-90. PubMed ID: 27069134
[TBL] [Abstract][Full Text] [Related]
36. HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
Galdy S; Lamarca A; McNamara MG; Hubner RA; Cella CA; Fazio N; Valle JW
Cancer Metastasis Rev; 2017 Mar; 36(1):141-157. PubMed ID: 27981460
[TBL] [Abstract][Full Text] [Related]
37. The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis.
Shen W; Xi H; Wei B; Chen L
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1003-9. PubMed ID: 24610446
[TBL] [Abstract][Full Text] [Related]
38. Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.
Frogne T; Laenkholm AV; Lyng MB; Henriksen KL; Lykkesfeldt AE
Breast Cancer Res; 2009; 11(1):R11. PubMed ID: 19239686
[TBL] [Abstract][Full Text] [Related]
39. HER3 expression is correlated to distally located and low-grade colon cancer.
Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
Acta Oncol; 2016 Jul; 55(7):875-80. PubMed ID: 26863446
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis.
Chen C; Yang JM; Hu TT; Xu TJ; Yan G; Hu SL; Wei W; Xu WP
Arch Med Res; 2013 Jul; 44(5):380-9. PubMed ID: 23871709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
